Priya Kumthekar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Priya Kumthekar

Aug 29, 2024, 16:48 | Insight

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe

JAMA Oncology shared a post on X about a recent paper by Kamran Ahmed et…

Aug 19, 2024, 09:44 | Insight

Narjust Florez: Interesting and hypothesis provoking research letter in JAMA Oncology

Narjust Florez shared a post on X by JAMA Oncology about a recent paper by…

Aug 13, 2024, 13:16 | Opinion

Hussein Tawbi: Honored to co-chair the SNO ASCO 2024 with Priya Kumthekar

Hussein Tawbi shared on X: “It has been a real honor to co-chair the 2024…

Aug 12, 2024, 10:48 | Insight

Hussein Tawbi: Reflecting on last 48 hours of SNOASCO24

Mark Chen, Resident at Duke University Hospital, shared a post by Hussein Tawbi, a Professor…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023